骨质发生不完美的综合性审查:当前的治疗方法和未来的创新
Sachin Chaugule1,2,3, Christodoulos Kypros Constantinou1, Aijaz Ahmad John1,2,3
1Division of Rheumatology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
Human gene therapy
|February 11, 2025
概括
骨质变生不完美 (OI) 是一种罕见的遗传骨疾病,导致骨脆弱. 新兴的基因和干细胞疗法对治疗OI充满希望,提供超越目前症状缓解的潜在长期解决方案.
科学领域:
- 遗传学和分子生物学
- 整形外科和再生医学
- 罕见疾病 罕见疾病
背景情况:
- 骨质变生不完美 (OI) 是一种罕见的遗传性疾病,其特点是骨脆,骨质较低,并经常发生骨折.
- 由于20多个基因中的病原性变异,OI表现出显著的临床和遗传异质性.
- 目前的治疗方法可以缓解症状,但不能解决OI的根本原因.
研究的目的:
- 为了提供一个全面的骨质变生不完美 (OI) 分类和病变的综述.
- 总结OI目前的管理策略.
- 探索新兴生物技术,包括干细胞和基因疗法,用于治疗OI.
主要方法:
- 关于骨质变生不完美的 (OI) 分类,发病和治疗的文献综述.
- 对当前多学科管理方法的分析.
- 对OI的新兴干细胞和基因向疗法的评估.
主要成果:
- OI是一种复杂的疾病,具有多样化的遗传基础和临床表现.
- 目前对OI的治疗主要是息性,重点是症状管理.
- 基因和干细胞疗法为新型OI治疗提供了有前途的途径.
结论:
- 创新的生物技术为治疗或长期治疗不完美的骨质生成提供了潜在的潜力.
- 需要进一步的研究和临床实施,才能充分发挥这些先进疗法的潜力.
- 重点是实现即将成功的治疗骨疾病,如OI.
相关概念视频
Fractures: Bone Repair
2.9K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
2.9K
Bone Remodeling
38.1K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.1K
What is the Skeletal System?
52.1K
Overview
52.1K
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
Bone Structure
47.9K
Within the skeletal system, the structure of a bone, or osseous tissue, can be exemplified in a long bone, like the femur, where there are two types of osseous tissue: cortical and cancellous.
47.9K


